Evenity (Romosozumab) Nutrition for Best Outcomes

Why Nutrition Matters Specifically During Romosozumab Treatment

Romosozumab works by blocking sclerostin, a protein that normally puts the brakes on osteoblast activity. When sclerostin is inhibited, osteoblasts (bone-forming cells) accelerate their work at a pace that has no equivalent among currently approved osteoporosis drugs. The FRAME trial (N=7,180) showed a 73% reduction in new vertebral fractures at 12 months compared with placebo, and bone mineral density at the lumbar spine rose by 13.3% in that same period [1].

That surge in bone formation is metabolically expensive. Osteoblasts need calcium, phosphate, collagen precursors, and a range of co-factors to mineralize new bone matrix. If those nutrients are not available in adequate supply, the drug's potential is partially wasted. Think of romosozumab as having hired a large construction crew. Nutrition is the building material.

The 12-Month Window is Non-Renewable

Romosozumab is prescribed for exactly 12 months. The FDA label does not permit re-treatment, and the bone-forming effect tapers significantly after the first few months [2]. Every week that passes with suboptimal nutrient intake is a week the accelerated bone-building machinery runs short of supplies. There is no second course to make up the deficit.

Hypocalcemia Risk is Real

The FDA prescribing information for romosozumab states that hypocalcemia must be corrected before starting treatment and that patients should be supplemented with calcium and vitamin D during therapy [2]. This is not a minor precaution. Rapid bone mineralization pulls calcium out of circulation. Inadequate dietary and supplemental calcium will worsen that drop, potentially causing symptomatic hypocalcemia (muscle cramps, numbness, cardiac arrhythmia in severe cases).

Calcium: The Most Time-Sensitive Nutrient

The National Osteoporosis Foundation and the Endocrine Society both recommend 1,000 to 1,200 mg of total calcium per day for postmenopausal women, with food sources preferred over supplements when achievable [3]. During romosozumab therapy, hitting that target consistently matters more than it does during baseline maintenance because bone turnover markers (specifically P1NP, a marker of formation) spike sharply in the first months of treatment [4].

How Much Calcium Is in Common Foods?

| Food | Serving | Calcium (mg) | |---|---|---| | Plain low-fat yogurt | 1 cup (245 g) | 415 | | Part-skim ricotta | 0.5 cup | 337 | | Cow's milk (2%) | 1 cup | 293 | | Fortified soy milk | 1 cup | 300 | | Cooked kale | 1 cup | 177 | | Canned sardines with bones | 3 oz | 325 | | White beans, cooked | 0.5 cup | 96 | | Fortified orange juice | 1 cup | 350 |

A patient who eats two servings of dairy, one serving of fatty fish, and two servings of leafy greens daily can approach 1,000 mg from food alone, leaving only a 200 to 400 mg gap for supplemental calcium.

Supplement Form and Timing

Calcium carbonate requires stomach acid for absorption and should be taken with food. Calcium citrate is absorbed without food and suits patients on proton pump inhibitors or with low gastric acid. Splitting doses to no more than 500 mg elemental calcium per serving optimizes absorption [3].

Avoid taking calcium supplements within 2 hours of iron supplements or high-oxalate foods like raw spinach or beet greens in very large amounts, as absorption is reduced.

Vitamin D: The Gatekeeper for Calcium Absorption

Without adequate vitamin D, up to 80% of dietary calcium may be malabsorbed from the gut. The Endocrine Society's 2011 clinical practice guideline for vitamin D deficiency in adults recommends maintaining serum 25-hydroxyvitamin D (25(OH)D) at or above 30 ng/mL, which typically requires 1,500 to 2,000 IU per day in adults at risk for deficiency [5].

The ARCH trial protocol required all participants to receive supplemental calcium (500 to 1,000 mg) and vitamin D (400 to 800 IU) daily during the study, and the trial still showed a 38% reduction in hip fracture risk when romosozumab was followed by alendronate versus alendronate alone [6]. Patients in real-world settings who do not supplement adequately may see smaller gains than the trial populations did.

Checking Your Level Before and During Treatment

A serum 25(OH)D test (CPT code 82306) before the first romosozumab injection tells you your baseline. If the result is below 20 ng/mL, your prescriber may recommend a loading dose (50,000 IU ergocalciferol weekly for 8 to 12 weeks) before maintenance dosing begins. Recheck at month 3 of treatment.

Food Sources of Vitamin D

Fatty fish top the list: 3 oz of sockeye salmon provides roughly 570 IU. Fortified cow's milk offers 115 to 130 IU per cup. Egg yolks provide about 40 IU each. Food alone rarely supplies 800 IU daily in typical eating patterns, so supplemental cholecalciferol (D3) is standard practice during romosozumab therapy.

Protein: Building the Collagen Scaffold

Bone is not purely mineral. Approximately 35% of bone by weight is organic matrix, and 90% of that matrix is type I collagen. Romosozumab activates osteoblasts to produce more collagen-rich osteoid (unmineralized bone matrix), which is then mineralized over subsequent weeks. That process requires dietary amino acids, particularly glycine, proline, and hydroxyproline.

How Much Protein Do Patients Need?

A 2017 systematic review and meta-analysis in JAMA Internal Medicine found that higher protein intake was associated with modestly greater bone mineral density and fewer hip fractures in older adults [7]. The researchers noted that protein intakes around 1.0 to 1.2 g per kg per day were associated with the strongest outcomes.

For a 65 kg woman, that translates to 65 to 78 g of protein per day. A 3.5 oz chicken breast provides about 30 g. Two eggs provide 12 g. One cup of Greek yogurt provides 17 g. Meeting the target through a varied diet is achievable.

Protein Timing

Spreading protein across three meals (rather than concentrating it at dinner) may improve muscle protein synthesis, which indirectly supports bone health by maintaining the muscle mass that protects against falls [8]. The USPSTF recommends exercise and fall-prevention interventions alongside pharmacological osteoporosis treatment [9].

Micronutrients That Support Bone Metabolism

Magnesium

Roughly 60% of total body magnesium resides in bone. Magnesium is a co-factor for alkaline phosphatase, the enzyme central to bone mineralization. The Recommended Dietary Allowance for magnesium in women over 51 is 320 mg per day [10]. Good food sources include pumpkin seeds (156 mg per oz), cooked black beans (60 mg per 0.5 cup), and whole-grain bread (24 mg per slice).

Vitamin K2

Vitamin K2 (menaquinone) activates osteocalcin, a protein that binds calcium to hydroxyapatite crystals in bone. Observational data from the Nurses' Health Study suggested women with the lowest vitamin K intakes had a 30% higher hip fracture risk than those with the highest intakes [11]. Natto (fermented soybeans) provides the highest known food source of MK-7 (menaquinone-7), roughly 850 mcg per 100 g. Hard aged cheeses and egg yolks also contribute smaller amounts.

Patients on warfarin should not change their vitamin K intake without medical guidance, as any shift can destabilize INR control.

Zinc and Copper

Zinc supports osteoblast differentiation, and copper is required for collagen cross-linking. Both are found in shellfish, legumes, nuts, and seeds. Deficiency in either is uncommon in people eating a varied diet, but older adults eating very restricted diets may benefit from a standard multivitamin providing 8 to 11 mg zinc and 0.9 mg copper.

Phosphorus

Hydroxyapatite (the mineral crystal in bone) is calcium phosphate. Phosphorus is rarely deficient in Western diets since it is abundant in protein-rich foods, dairy, and processed foods. The concern is more about excess phosphorus from ultra-processed foods, which may disrupt calcium-phosphorus homeostasis. Keeping ultra-processed food intake low benefits both bone and cardiovascular health.

Foods and Habits That May Reduce Romosozumab's Effectiveness

Excess Sodium

High sodium intake increases urinary calcium excretion. Every extra 2,300 mg of dietary sodium causes the kidneys to excrete approximately 40 to 60 mg of calcium [12]. A patient eating a high-sodium diet (above 3,400 mg per day) and failing to compensate with extra calcium intake may end up in negative calcium balance even while supplementing. Reading labels and limiting canned soups, deli meats, and packaged snacks helps substantially.

Heavy Alcohol Consumption

The equivalent of more than one standard drink per day suppresses osteoblast function directly and increases fall risk through balance and coordination impairment. The ARCH trial excluded heavy drinkers; real-world patients who drink heavily may not replicate trial outcomes. Limiting alcohol to no more than one drink per day is a reasonable clinical goal during the 12-month romosozumab course.

Very-Low-Calorie Diets

Extreme caloric restriction (below approximately 1,000 kcal per day) reduces circulating IGF-1, a growth factor that supports osteoblast activity. Patients managing weight during romosozumab treatment should target a modest caloric deficit if needed rather than aggressive restriction, and should ensure protein and micronutrient targets are still met.

Smoking

Smoking is an independent risk factor for osteoporosis and reduces bone mineral density through multiple mechanisms including reduced estrogen production, impaired calcium absorption, and direct osteotoxic effects of nicotine metabolites [13]. No clinical trial has tested whether smoking blunts romosozumab's effect specifically, but the mechanism is plausible. Smoking cessation resources should be offered to all patients on romosozumab.

Caffeine

Moderate caffeine intake (up to 400 mg per day, roughly four 8-oz cups of coffee) has not been shown to significantly reduce bone density when calcium intake is adequate. The concern about caffeine arises mainly at high intakes combined with low calcium consumption. A patient hitting 1,200 mg of calcium daily need not eliminate coffee.

The Cardiovascular Nutrition Consideration

Romosozumab's FDA label includes a boxed warning about increased risk of myocardial infarction, stroke, and cardiovascular death based on the ARCH trial, in which the romosozumab arm had a higher rate of serious cardiovascular events than the alendronate arm (2.5% vs. 1.9%) during the 12-month treatment phase [2].

This means that patients with existing cardiovascular disease may not be appropriate candidates, and all patients should consider heart-healthy dietary habits during treatment. The American Heart Association's dietary guidelines, which emphasize fruits, vegetables, whole grains, lean proteins, and limited saturated fat and sodium, align well with bone-health nutrition goals [14]. Both priorities point toward the same general eating pattern.

A Practical Day of Eating During Romosozumab Therapy

The following sample day is not a prescription. It illustrates how common foods can meet calcium, protein, vitamin D, and micronutrient targets simultaneously.

Breakfast: 1 cup low-fat Greek yogurt (415 mg calcium, 17 g protein) topped with 1 oz pumpkin seeds (156 mg magnesium) and a handful of blueberries. 1 cup fortified orange juice (350 mg calcium, 137 IU vitamin D).

Lunch: Large salad with 3 oz canned sardines with bones (325 mg calcium, 26 g protein), cooked kale (177 mg calcium), white beans (96 mg calcium), olive oil, and lemon dressing.

Afternoon snack: 2 hard-boiled eggs (12 g protein, 80 IU vitamin D) with whole-grain crackers.

Dinner: 4 oz baked salmon fillet (570 IU vitamin D, 25 g protein), 0.5 cup cooked black beans (60 mg magnesium), steamed broccoli, and a glass of fortified soy milk (300 mg calcium).

Running totals: approximately 1,663 mg calcium, 80 g protein, 867 IU vitamin D, 236 mg magnesium. A 1,000 IU vitamin D3 supplement taken at dinner would bring vitamin D to roughly 1,867 IU, within the 800 to 2,000 IU daily target for patients with borderline-sufficient levels.

Monitoring: What Your Lab Results Tell You

Two bone turnover markers guide romosozumab therapy monitoring. P1NP (procollagen type 1 N-terminal propeptide) rises sharply in the first months if romosozumab is working. Beta-CTX (carboxy-terminal collagen crosslinks) falls, reflecting reduced resorption. Calcium and phosphorus panels can flag hypocalcemia early.

If a 3-month follow-up shows P1NP has not risen significantly, the clinical team should investigate whether calcium and vitamin D repletion was adequate before the treatment began, because substrate deficiency is one modifiable explanation.

Serum albumin-corrected calcium below 8.5 mg/dL on a standard metabolic panel warrants a dietary review and possibly a supplement dose adjustment before the next injection.

Transitioning to Antiresorptive Therapy After Month 12

Romosozumab is always followed by an antiresorptive drug (bisphosphonate or denosumab) to preserve the gains made. Alendronate 70 mg weekly is the most common choice in the United States, based on the ARCH trial sequence [6]. The nutritional rules do not change at this transition. Calcium and vitamin D targets remain the same. Bisphosphonates add one new dietary instruction: oral bisphosphonates must be taken 30 to 60 minutes before any food, beverage (other than plain water), or other medications to ensure adequate absorption.

Patients who switch to denosumab (Prolia) should be aware that stopping denosumab abruptly carries a risk of rebound vertebral fractures, and must continue consistent calcium and vitamin D intake to mitigate that risk.

Putting It All Together: A Checklist for Patients

• Confirm your serum 25(OH)D is above 30 ng/mL before injection number one.
• Reach 1,000 to 1,200 mg of calcium daily, preferably from food with supplements as needed.
• Take no more than 500 mg of elemental calcium at any one sitting.
• Eat protein at every meal to support collagen matrix production.
• Keep sodium below 2,300 mg per day to limit urinary calcium losses.
• Limit alcohol to one drink per day or fewer.
• Tell your provider about any diet change that affects vitamin K intake if you are on warfarin.
• Schedule a metabolic panel and bone-turnover-marker check at month 3.
• Do not skip the antiresorptive drug prescribed after your 12-month romosozumab course ends.